Filing Details

Accession Number:
0000899243-19-006332
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-05 21:05:34
Reporting Period:
2019-03-01
Accepted Time:
2019-03-05 21:05:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1351288 Gw Pharmaceuticals Plc GWPH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
941388 Dr W Geoffrey Guy Sovereign House, Vision Park, Histon
Cambridge X0 CB24 9BZ
Executive Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2019-03-01 7 $0.00 8,465,528 No 4 M Direct
Ordinary Shares Acquisiton 2019-03-01 15,336 $0.00 8,480,864 No 4 M Direct
Ordinary Shares Acquisiton 2019-03-01 25,914 $0.00 8,506,778 No 4 M Direct
Ordinary Shares Acquisiton 2019-03-01 345,517 $0.00 8,852,295 No 4 M Direct
Ordinary Shares Acquisiton 2019-03-01 182,171 $3.39 9,034,466 No 4 M Direct
Ordinary Shares Acquisiton 2019-03-01 7,055 $0.00 9,041,521 No 4 M Direct
Ordinary Shares Disposition 2019-03-01 300,000 $14.49 103,925 No 4 S Indirect By personal pension plan
Ordinary Shares Disposition 2019-03-04 900,000 $14.75 8,141,521 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Indirect By personal pension plan
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Options Disposition 2019-03-01 7 $0.00 7 $0.00
Ordinary Shares Stock Options Disposition 2019-03-01 15,336 $0.00 15,336 $0.00
Ordinary Shares Stock Options Disposition 2019-03-01 25,914 $0.00 25,914 $0.00
Ordinary Shares Stock Options Disposition 2019-03-01 345,517 $0.00 345,517 $0.00
Ordinary Shares Stock Options Disposition 2019-03-01 182,171 $0.00 182,171 $3.39
Ordinary Shares Stock Options Disposition 2019-03-01 7,055 $0.00 7,055 $0.00
Ordinary Shares Stock Options Acquisiton 2019-03-01 75,252 $0.00 75,252 $14.33
Ordinary Shares Stock Options Acquisiton 2019-03-01 142,824 $0.00 142,824 $0.00
Ordinary Shares Stock Options Acquisiton 2019-03-01 10,704 $0.00 10,704 $0.00
Ordinary Shares Stock Options Acquisiton 2019-03-01 10,704 $0.00 10,704 $0.00
Ordinary Shares Stock Options Acquisiton 2019-03-01 10,704 $0.00 10,704 $0.00
Ordinary Shares Stock Options Acquisiton 2019-03-01 10,704 $0.00 10,704 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-02-15 2026-02-15 No 4 M Direct
0 2018-08-10 2027-08-10 No 4 M Direct
0 2019-02-15 2026-02-15 No 4 M Direct
0 2019-02-15 2026-02-15 No 4 M Direct
0 2019-02-15 2026-02-15 No 4 M Direct
9,262 2019-02-26 2028-02-26 No 4 M Direct
75,252 2022-03-01 2029-03-01 No 4 A Direct
142,824 2022-03-01 2029-03-01 No 4 A Direct
10,704 2020-03-01 2029-03-01 No 4 A Direct
10,704 2021-03-01 2029-03-01 No 4 A Direct
10,704 2022-03-01 2029-03-01 No 4 A Direct
10,704 2023-03-01 2029-03-01 No 4 A Direct
Footnotes
  1. Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares of the Issuer ("ADS"). Each ADS represents twelve ordinary shares of the Issuer.
  2. Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of March 1, 2019.
  3. The 300,000 ordinary shares sold pursuant to the reported transaction are represented by ADSs. Following the reported transaction, 103,920 shares of the remaining shares are represented by ADSs.
  4. The price reported in Column 4 is price per ordinary share converted from price per ADS.
  5. Represented by ADSs.
  6. Granted pursuant to the Issuer's Long-Term Incentive Plan
  7. The reported options are options to purchase ADSs.
  8. The exercise price reported is price per ordinary share converted from price per ADS ($172.01).